Pneumococcal 20-Valent Conjugate Vaccine: all 25 studies that test it
Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate 20vPnC in Healthy Chinese InfantsRecruitingNCT07754539Phase 3
- A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)RecruitingNCT07300267Phase 1
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their BabiesRecruitingNCT07160244Phase 3
- Genetic Variation in IgG in Alpha 1 Antitrypsin DeficiencyRecruitingNCT07135427Phase 4
- Vaccine Immunity and Inflammation in the Aging Person Living With HIVRecruitingNCT06514547Phase 4
- Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL TrialRecruitingNCT05183854Phase 2
- Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older AdultsCompletedNCT05879107Phase 3Results posted
- A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India.CompletedNCT05875727Phase 3Results posted
- A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy InfantsCompletedNCT05412030Phase 2Results posted
- Safety and Immunogenicity of 20vPnC in Toddlers With 2 Prior Doses of Prevenar 13CompletedNCT05408429Phase 3Results posted
- Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2CompletedNCT04887948Phase 3Results posted
- 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and TaiwanCompletedNCT04875533Phase 3Results posted
- Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of AgeCompletedNCT04642079Phase 3Results posted
- 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy InfantsCompletedNCT04546425Phase 3Results posted
- 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese InfantsCompletedNCT04530838Phase 3Results posted
- 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy InfantsCompletedNCT04382326Phase 3Results posted
- 20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy InfantsCompletedNCT04379713Phase 3Results posted
- Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal VaccinationCompletedNCT03835975Phase 3Results posted
- Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve AdultsCompletedNCT03828617Phase 3Results posted
- Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve AdultsCompletedNCT03760146Phase 3Results posted
- A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and InfantActive, not recruitingNCT07023081Phase 1
- A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese AdultsCompletedNCT07019909Phase 1
- Immunogenicity and Clinical Efficacy of 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Lymphoma Survivors After Treatment With Anti-CD20 TherapyActive, not recruitingNCT06049134Phase 4
- Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 YearsStatus unknownNCT05767606Phase 4
- A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and TaiwanCompletedNCT05512819Phase 3